Strong Industry Reputation With over 50 years of cGMP-compliant pharmaceutical manufacturing experience and partnerships with government agencies like NIH, CDC, and NCI, University of Iowa Pharmaceuticals has a trusted reputation that can facilitate collaborations in advanced drug development and manufacturing projects.

Diverse Capabilities Offering a comprehensive range of dosage forms including sterile injectables, lyophilized powders, oral and topical liquids, and capsules positions UI Pharmaceuticals as a versatile partner capable of handling complex formulation development and manufacturing needs for biotech and pharma clients.

Geographic and Market Reach Supported by international certifications and the ability to support EU product launches, the company is well-positioned to expand its services globally, creating opportunities for partnerships with pharmaceutical companies seeking compliant manufacturing facilities.

Innovative Research Focus Recent development of hydrogen sensors for nuclear plant safety demonstrates a capacity for innovative research and technology development, presenting opportunities for sales of specialized analytical and safety testing equipment.

Growing Financial Scale With revenue estimates between 250 million and 500 million dollars and a robust client portfolio including startups and large enterprises, the company has the financial capacity and market presence to invest in new manufacturing technologies or expand service offerings.